Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active Shortage

VIMOVO

XEDITON PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of VIMOVO in Canada?

Yes. VIMOVO 375MG 20MG has an active shortage reported to Health Canada (last updated September 11, 2026).

Why is VIMOVO not available?

The reason the manufacturer reported: Demand increase for the drug.

When will VIMOVO be available again?

The manufacturer's estimated resolution date is October 31, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist
StatusActive Shortage
Same-ingredient products on fileNone found
Expected resolution~33 days remaining (estimate)
Affected strength375MG 20MG
Last updated2026-09-11

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-10-31

~33 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02361701

Strength

375MG 20MG

Dosage Form

TABLET (IMMEDIATE- AND DELAYED-RELEASE)

Route

ORAL

Active Ingredient

NAPROXEN ESOMEPRAZOLE

Tier

Unrated

Last Updated

2026-09-11

Reason for Shortage

Demand increase for the drug.

Other Products from XEDITON PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.